Application of the Trend of miRNA Expression Levels in APP/PS1 Mice Plasma for the Early Diagnosis of Alzheimer’s Disease
Authors:
- 12 February 2025
- journal article
- research article
- Published by Springer Nature in Molecular Neurobiology
- Vol. 62 (6) , 7792-7804
Abstract
Alzheimer’s disease (AD) is the most common form of dementia and seriously affects people’s quality of life. In recent years, many circulating microRNAs (miRNAs) have been reported as potential diagnostic biomarkers for AD. However, there are no reliable miRNAs for early diagnosis of AD because miRNAs are dynamically changing during the disease process. The present study was to seek reliable biomarkers for early diagnosis of AD by detecting changes in miRNAs in plasma from young APPswe/PS1Δ9 double-transgenic mice (APP/PS1 mice) using a quantitative real-time PCR (qRT-PCR) method. Some behavioral experiments and pathological tests were used to characterize the progress of AD in APP/PS1 transgenic mice. The results showed that the expression levels of several plasma miRNAs targeting BACE1 and APP showed consistent trends in the early stages of APP/PS1 mice. The expression levels of miR-34a-5p, miR-29c-3p, miR-107-3p, and miR-101a-3p in the plasma of APP/PS1 female mice decreased with cognitive decline, demonstrating their potential as biomarkers for early diagnosis of female AD patients. The expression levels of these miRNAs fluctuated significantly in APP/PS1 male mice, and the reason for this difference may be related to the biological sex differences in AD. This fluctuation may serve as an indicative risk signal for the early stage of AD in male patients.Keywords
Funding Information
- National Natural Science Foundation of China (21904096, 21904096, 21904096)
This publication has 85 references indexed in Scilit:
- Let-7c-5p Down Regulates the Proliferation of Colorectal Cancer Through the MAPK-ERK-Signaling PathwayBiochemical Genetics, 2023
- APP-BACE1 Interaction and Intracellular Localization Regulate Aβ Production in iPSC-Derived Cortical NeuronsCellular and Molecular Neurobiology, 2023
- Amyloid β structural polymorphism, associated toxicity and therapeutic strategiesCellular and Molecular Life Sciences, 2021
- An investigation of microRNA‐103 and microRNA‐107 as potential blood‐based biomarkers for disease risk and progression of Alzheimer's diseaseJournal of Clinical Laboratory Analysis, 2019
- miR‐34a/BCL‐2 signaling axis contributes to apoptosis in MPP+‐induced SH‐SY5Y cellsMolecular Genetics & Genomic Medicine, 2018
- Analysis of Micro-RNA Expression by qPCR on a Microfluidics Platform for Alzheimer’s Disease Biomarker Discovery2018
- BACE1 inhibition more effectively suppresses initiation than progression of β-amyloid pathologyActa Neuropathologica, 2018
- Effect of cadmium on kitl pre‐mRNA alternative splicing in murine ovarian granulosa cells and its associated regulation by miRNAsJournal of Applied Toxicology, 2017
- Alzheimer’s Disease2012
- Characterization of plasma β‐secretase (BACE1) activity and soluble amyloid precursor proteins as potential biomarkers for Alzheimer's diseaseJournal of Neuroscience Research, 2012